First Page | Document Content | |
---|---|---|
Date: 2016-08-08 11:22:57 | AbstractProspective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCCAdd to Reading ListSource URL: www.ctueoc.chDownload Document from Source WebsiteFile Size: 968,77 KBShare Document on Facebook |